Carematix Launches the World’s First Connected Blinded Blood Pressure Monitor and Scale for Clinical Trials

Carematix's blinded blood pressure monitor and scale, the first devices built specifically for clinical trials, letting patients take readings without seeing them while still transmitting real-time data to investigators without breaking the study blind. For clinicians and researchers running trials, this solves a real problem patients self-adjusting behavior or medication based on seeing their own numbers, which can quietly skew results and undermine data integrity. It is especially useful for anyone involved in trial design or safety monitoring, since the devices still allow rapid intervention if a patient's readings signal danger, without compromising blinding or risking the credibility of the trial's outcomes.